"ATTR amyloidosis was characterized by distinct patterns of functional impairment across all disease phenotypes, attributable to multiple physiological mechanisms. Multiple CPET parameters were ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. The greatest areas of unmet needs. I think ...

Three patients with light chain amyloidosis have been treated with CAR T cell therapy in the first European clinical trial testing the safety and efficacy of this immunotherapy in this patient group, ...

Serum and urine immunofixation and serum free light chain assay is recommended to increase clinical suspicion of cardiac AL amyloidosis for individuals with suspected cardiac amyloidosis. HealthDay ...

Healio spoke with Joban Vaishnav, MD, director of the Johns Hopkins Comprehensive Amyloidosis Center, about the process of diagnosing amyloidosis, the importance of multidisciplinary care in patients ...

Cardiac amyloidosis is underrecognized in patients with heart failure; however, recent improvements in the understanding of this disease have led to developments in diagnosis and treatment. Cardiac ...

Interviewer: Amyloidosis is a rare and possibly debilitating disease, which affects about 4,000 people a year in the United States. If left untreated, the disease can cause severe organ damage, so ...

England-based Ultromics’ AI technology could improve detection of cardiac amyloidosis on routine echocardiograms, according to a new study from the company. The results were presented at the American ...

It can be tough to share the news of a genetic health condition, but doing so empowers your relatives to take charge of their health. ATTR occurs when the protein transthyretin (TTR), which is made in ...

This transcript has been edited for clarity. Michelle M. Kittleson, MD: Welcome to Medscape InDiscussion: Heart Failure. I'm your host, Dr Michelle Kittleson. This is the seventh episode of our ...